You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cemiplimab

Showing 26 - 50 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Adenocarcinoma Trial in New York, Providence (Motixafortide, Cemiplimab,

Recruiting
  • Pancreatic Cancer
  • +2 more
  • New York, New York
  • +1 more
Nov 7, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in United States (REGN5668, Cemiplimab, REGN4018)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Duarte, California
  • +7 more
Sep 26, 2022

Head Neck Cancer, Head Cancer, Head Cancer Neck Trial in United States (drug, procedure, radiation)

Recruiting
  • Head and Neck Cancer
  • +5 more
  • Basking Ridge, New Jersey
  • +5 more
Jan 19, 2023

Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne

Not yet recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +3 more
  • Cemiplimab
  • Melbourne, Victoria, Australia
    Peter MacCallum Cancer Centre
May 17, 2023

Mycosis Fungoides Trial in Edmonton (Cemiplimab)

Not yet recruiting
  • Mycosis Fungoides
  • Cemiplimab
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Sep 12, 2022

Cancer, Tumor, Solid, Malignant Tumor Trial (OR502, Cemiplimab)

Not yet recruiting
  • Cancer
  • +6 more
  • (no location specified)
Oct 16, 2023

Cutaneous Squamous Cell Carcinoma Trial in Italy (Cemiplimab)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Cemiplimab
  • Bagno A Ripoli, Firenze, Italy
  • +6 more
Jul 27, 2022

Squamous Cell Carcinoma of Head and Neck Trial in Spain, United States (REGN6569, Cemiplimab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Los Angeles, California
  • +9 more
Jun 20, 2022

Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma Trial in United States (Cemiplimab)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Cemiplimab
  • Redwood City, California
  • +8 more
Mar 28, 2022

HPV-Related Squamous Cell Carcinoma Trial in Baltimore (Cemiplimab)

Recruiting
  • HPV-Related Squamous Cell Carcinoma
  • Cemiplimab
  • Baltimore, Maryland
    Johns Hopkins University
Jan 10, 2022

Invasive Breast Cancer Trial in Milwaukee (Cemiplimab, Paclitaxel, Carboplatin (not mandatory))

Recruiting
  • Invasive Breast Cancer
  • Cemiplimab
  • +4 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & Medical College of Wisconsin
Apr 1, 2022

Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer, Recurrent Primary Peritoneal Cancer Trial in Australia, Belgium,

Recruiting
  • Recurrent Ovarian Cancer
  • +2 more
  • Birmingham, Alabama
  • +14 more
Oct 11, 2022

NSCLC, Hepatocellular Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in New York (cemiplimab, Platinum Doublet)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • cemiplimab
  • Platinum Doublet
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 24, 2021

Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Metastatic Head and Neck Squamous Cell Carcinoma,

Recruiting
  • Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +24 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
May 18, 2022

Cutaneous Squamous Cell Carcinoma, Skin Cancer, Squamous Cell Carcinoma Trial in United States (Cemiplimab, Radiotherapy)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • +6 more
  • Cemiplimab
  • Radiotherapy
  • Aurora, Colorado
  • +11 more
Oct 12, 2022

Natural Killer/T-cell Lymphoma, Relapsed Natural Killer/T-cell Lymphoma, Refractory Natural Killer/T-cell Lymphoma Trial in

Recruiting
  • Natural Killer/T-cell Lymphoma
  • +2 more
  • Seoul, Kangnamgu, Korea, Republic of
    Samsung Medical Center
Sep 22, 2021

Metastatic Solid Tumor Trial in Groningen (89Zr-DFO-REGN3767, Cemiplimab)

Recruiting
  • Metastatic Solid Tumor
  • 89Zr-DFO-REGN3767
  • Cemiplimab
  • Groningen, Netherlands
    University Medical Center Groninen
Jan 24, 2022

Cutaneous Squamous Cell Carcinoma Trial in Australia, Germany, United States (Cemiplimab)

Active, not recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Cemiplimab
  • Palo Alto, California
  • +21 more
Apr 5, 2022

Solid Tumor, Adult, Relapsed Cancer, Refractory Cancer Trial (HST-1011, Cemiplimab)

Not yet recruiting
  • Solid Tumor, Adult
  • +2 more
  • (no location specified)
Dec 14, 2022

NSCLC Trial in Amsterdam (Ipilimumab, Cemiplimab, SBRT)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Amsterdam, Noord-Holland, Netherlands
    Antoni van Leeuwenhoek - Netherlands Cancer Institute
Jan 10, 2023

CemiplimAb Survivorship Epidemiology

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Basal Cell Carcinoma
  • cemiplimab
  • Huntsville, Alabama
  • +52 more
Dec 14, 2022

Cervical Cancer Trial in Worldwide (Cemiplimab, ISA101b)

Recruiting
  • Cervical Cancer
  • Cemiplimab
  • ISA101b
  • Tucson, Arizona
  • +31 more
Jul 22, 2022

Squamous Cell Carcinoma of the Oropharynx, HPV16 Positive Trial in Worldwide (biological, drug, other)

Recruiting
  • Squamous Cell Carcinoma of the Oropharynx
  • HPV16 Positive
  • ISA101b
  • +2 more
  • Duarte, California
  • +75 more
Sep 25, 2022

Glioblastoma Trial in United States (biological, radiation, drug)

Active, not recruiting
  • Glioblastoma
  • INO-5401
  • +4 more
  • Duarte, California
  • +20 more
Aug 8, 2022

Advanced or Metastatic Merkel Cell Carcinoma, Advanced or Metastatic Cutaneous Squamous Cell Carcinoma, Advanced or Metastatic

Terminated
  • Advanced or Metastatic Merkel Cell Carcinoma
  • +4 more
  • Tucson, Arizona
  • +25 more
Mar 30, 2022